PISCATAWAY, N.J., Nov. 10,
2024 /PRNewswire/ -- GenScript Biotech Corporation
("GenScript"), a global leader in life sciences services and
products, has announced the establishment of new operations site
and logistics center in Sydney,
Australia. This strategic expansion represents a significant
milestone in GenScript's continued commitment to supporting the
rapid growth of the biotechnology sector in Australia. It also underscores the company's
determination to strengthen GenScript's presence in the
Asia-Pacific region and globally,
advancing innovative solutions that address the evolving needs of
the industry.
The new Sydney facility will
significantly enhance GenScript's ability to serve customers across
the region, ensuring faster and more efficient delivery of research
reagents and products. With a local presence, Australian
researchers and biotech companies will no longer need to navigate
the complexities of permit applications, customs clearance, and tax
payments, streamlining the procurement process, and allowing them
to focus on advancing their groundbreaking research and
innovation.
A key highlight of the Sydney
site is the introduction of next-day shipping for high-demand
products such as off-the-shelf mRNA, growth factors, Cas proteins,
and more. This expedited service ensures that researchers and
biotech companies can access essential materials with unprecedented
speed, accelerating their scientific discoveries and development
efforts.
Sherry Shao, GenScript's rotating
CEO, commented on the expansion: "Establishing a logistics hub
in Sydney enables us to deliver
more localized support to our Australian partners. We see this as
more than just an operational expansion – it's about building
long-term relationships within the region's biotech ecosystem. By
removing import barriers and offering next-day delivery on key
products, we are helping our customers focus entirely on advancing
their research, without the logistical challenges that previously
existed."
"This new facility strengthens our connection to local
researchers and companies, enabling us to better understand their
unique needs and challenges. We're here to provide tailored
solutions that empower innovation and scientific
breakthroughs," said Dr. Janice
Jin, President of GenScript Asia Pacific. She continued:
"Australia plays a pivotal role
in the Asia-Pacific and Oceania
biotech landscape, and we are committed to supporting its continued
growth by offering faster, more efficient access to the
high-quality products and services."
Consistent with GenScript's global effort, this new facility
underscores GenScript's mission to revolutionize the supply chain
for Australian biotech companies, fostering a more dynamic and
efficient research environment. By removing logistical barriers and
offering next-day shipping for key products, GenScript is
empowering the biotechnology community to focus on innovation and
discovery.
About GenScript Biotech Corporation
GenScript Biotech Corporation (HK.1548) is a world leader in
technologies and services for life science R&D and manufacture.
Built upon its solid DNA synthesis technology, the company
comprises four major business units: a life-science services and
products business unit, a biologics contract development and
manufacturing organization (CDMO) business unit, an industrial
synthetic products business unit, and Cell Therapy Business Unit.
GenScript accelerates scientific discovery and therapeutic
breakthrough with its customers. Since its founding in New Jersey, USA in 2002, GenScript has
expanded its operations to serve more than 200,000 customers across
100 countries with a dedicated team of 5060 employees. As of
June 30, 2024, over 100,000
peer-reviewed journal articles worldwide had cited GenScript 's
services and products. Guided by its mission to make people and
nature healthier through biotechnology, GenScript strives to become
the most trustworthy biotech company in the world.
For more information, please visit GenScript Biotech's official
website
https://www.genscript.com
View original
content:https://www.prnewswire.com/news-releases/genscript-biotech-sets-up-new-operations-and-logistics-hub-in-sydney-australia-302300748.html
SOURCE GenScript Biotech Corporation
